EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

β 3 ‐adrenoceptor agonism exerts lung protection in a rat model of bronchopulmonary dysplasia

Alessandro Pini, Patrizia Nardini, Virginia Zizi, Marta Molino, Maura Calvani, Francesco Carrozzo, Rachele Amato, Daniele Guasti, Denise Biagini, Fabio di Francesco, Ludovico Silvestri, Alessandra Franceschini und 3 weitere

British Journal of Pharmacology · 2026

DOI: 10.1111/bph.70333 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Pharmacology, 2026. Verfasst von Alessandro Pini und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy. Hauptthemen laut MEDLINE: Bronchopulmonary Dysplasia, Adrenergic beta-3 Receptor Agonists, Lung, Ethanolamines. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Ministry of University and Research, European Union, NextGenerationEU, Meyer Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Absract Background and Purpose Bronchopulmonary dysplasia (BPD) affects premature newborns, particularly those receiving supplemental oxygen therapy. Exposure of underdeveloped lungs to oxygen levels higher than the intrauterine environment causes oxidative stress, impairing alveolarisation, vascularisation and causing fibrosis. The β 3 ‐adrenoceptor could represent a promising target for BPD treatment because of its oxygen‐dependent regulation, ability to reduce oxidative stress and protection against intestinal hyperoxia‐induced damage. Experimental Approach In this study, neonatal rat pups were reared under hyperoxia for 2 weeks to induce a BPD‐like disease and treated with the β 3 ‐adrenoceptor agonist BRL37344 (1, 3 or 6 mg kg −1 ). Key Results Through oxidative stress, hyperoxia decreases pulmonary volume, impairs alveolarisation and vascularisation, and causes fibrosis and type II pneumocyte hyperplasia, thereby reducing survival rates. BRL37344 at 3 mg kg −1 counteracted these alterations, doubling survival rates. Conclusions and Implications Our findings demonstrate a new role for β 3 ‐adrenoceptors in protecting the lungs from hyperoxic injury, suggesting its pharmacological activation as a strategy for treating Bronchopulmonary dysplasia of prematurity and, possibly, other lung fibrosis‐related disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bronchopulmonary DysplasiaAdrenergic beta-3 Receptor AgonistsLungEthanolaminesReceptors, Adrenergic, beta-3AnimalsDisease Models, AnimalAnimals, NewbornRatsOxidative StressHyperoxiaFemale

Stichwörter der Autor:innen

PDGRFbronchopulmonary dysplasialungoxidative stressprematurityβ3‐adrenoceptor

Substanzen

Adrenergic beta-3 Receptor AgonistsBRL 37344EthanolaminesReceptors, Adrenergic, beta-3

Autor:innen und Institutionen

  • Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
  • Unit of Translational and Precision Medicine, Meyer Children's Hospital IRCCS, Florence, Italy.
  • Department of Chemistry and Industrial Chemistry, University of Pisa, Pisa, Italy.
  • National Research Council-National Institute of Optics (CNR-INO), Sesto Fiorentino, Italy.
  • Neonatology and Neonatal Intensive Care Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.

Förderung

  • Italian Ministry of University and Research
  • European Union, NextGenerationEU
  • Meyer Foundation
  • Intesa San Paolo

Zitieren

APA

Pini, A., Nardini, P., Zizi, V., Molino, M., Calvani, M., Carrozzo, F., Amato, R., Guasti, D., Biagini, D., di Francesco, F., Silvestri, L., Franceschini, A., Bani, D., Imbimbo, E., & Filippi, L. (2026). β 3 ‐adrenoceptor agonism exerts lung protection in a rat model of bronchopulmonary dysplasia. British Journal of Pharmacology. https://doi.org/10.1111/bph.70333

Vancouver

Pini A, Nardini P, Zizi V, Molino M, Calvani M, Carrozzo F, et al. β 3 ‐adrenoceptor agonism exerts lung protection in a rat model of bronchopulmonary dysplasia. British Journal of Pharmacology. 2026. doi:10.1111/bph.70333

BibTeX
@article{Pini2026,
  author = {Pini, Alessandro and Nardini, Patrizia and Zizi, Virginia and Molino, Marta and Calvani, Maura and Carrozzo, Francesco and Amato, Rachele and Guasti, Daniele and Biagini, Denise and di Francesco, Fabio and Silvestri, Ludovico and Franceschini, Alessandra and Bani, Daniele and Imbimbo, Elisa and Filippi, Luca},
  title = {β 3 ‐adrenoceptor agonism exerts lung protection in a rat model of bronchopulmonary dysplasia},
  journal = {British Journal of Pharmacology},
  year = {2026},
  doi = {10.1111/bph.70333}
}
Kostenlos starten →